Stay updated with breaking news from Bhatnagar Anish. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Shares of Soleno Therapeutics, Inc. (NASDAQ:SLNO – Get Free Report) were up 3.1% during trading on Wednesday . The company traded as high as $42.04 and last traded at $42.04. Approximately 65,481 shares traded hands during mid-day trading, a decline of 82% from the average daily volume of 360,998 shares. The stock had previously closed […]
Soleno Therapeutics (NASDAQ:SLNO – Free Report) had its price target cut by Oppenheimer from $65.00 to $59.00 in a research report report published on Monday, Benzinga reports. They currently have an outperform rating on the stock. A number of other research analysts also recently weighed in on SLNO. Stifel Nicolaus assumed coverage on shares of […]
Soleno Therapeutics, Inc. (NASDAQ:SLNO – Get Free Report) CEO Bhatnagar Anish sold 18,980 shares of the firm’s stock in a transaction on Monday, April 1st. The stock was sold at an average price of $41.34, for a total value of $784,633.20. Following the sale, the chief executive officer now owns 152,790 shares in the company, […]
Soleno Therapeutics Inc (NASDAQ:SLNO), a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for the treatment of rare diseases.
Shares of Soleno Therapeutics, Inc. (NASDAQ:SLNO – Get Free Report) were up 5.6% on Tuesday . The company traded as high as $44.06 and last traded at $44.00. Approximately 97,613 shares traded hands during trading, a decline of 68% from the average daily volume of 301,848 shares. The stock had previously closed at $41.67. Wall […]